EGF Potentiation of VEGF Production Is Cell Density Dependent in H292 EGFR Wild Type NSCLC Cell Line

Non-small cell lung cancer (NSCLC) affects millions of patients each year worldwide. Existing therapies include epidermal growth factor receptor (EGFR) inhibition using small molecules or antibodies with good efficacy. Unfortunately, intrinsic and acquired resistance to EGFR therapy remains a persis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranayhossaini, Daniel J., Lu, Jin, Mabus, John, Gervais, Alexis, Lingham, Russell B., Fursov, Natalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227184/
https://www.ncbi.nlm.nih.gov/pubmed/25272226
http://dx.doi.org/10.3390/ijms151017686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227184/
https://www.ncbi.nlm.nih.gov/pubmed/25272226
http://dx.doi.org/10.3390/ijms151017686

Ejemplares similares